Antibody Vaccines Market Intelligence

best-value

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

 No Additional Benefits

Subscription Benefits:

  • PRO access to New Beroe LiVE*
  • Unlimited updates on the Report*
  • Supplier Watchlist for 3 suppliers*
  • Supplier Shortlisting Tool*

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

*These features will be unlocked on the new Beroe LiVE when it launches (Q3, 2020)

Are you looking for answers on Antibody Vaccines category?

Are you looking for answers on Antibody Vaccines category?

  • What are the key trends in Antibody Vaccines category?
  • Am I paying the right price?
  • Am I working with the right supplier?
  • What are the major challenges and risks in Antibody Vaccines industry?
  • How is Antibody Vaccines industry performing?

Over 50,000+ users trust Beroe

Report Coverage

  • Antibody Vaccines Market Analysis
  • Market Overview
  • Market Trends
  • Antibody Vaccines Sourcing Practices

Production Size

Global Production Size/ Capacity

$3.28 Billion in 2018

CAGR

6.2%

Expected Global Production Size/ Capacity by 2022

$4.19 Billion

Table of Contents

  1. Executive Summary
  2. COVID – 19 Impact

 

  1. Antibody Vaccines Market Analysis
  2. Market Overview
  3. Market Trends
  4. Regional Analysis – PDS
  5. Porter’s Five Forces Analysis
  6. SWOT analysis
  1. Antibody Vaccines Sourcing Practices
  2. Sourcing Practices
  1. Antibody Vaccines Innovation Framework
  2. Technological Innovation
  3. Digital Trends Observed in The Vaccine Ecosystem

Want a more detailed personalised report?

Antibody Vaccines Global Market Outlook:

Market Growth: CAGR growth rate: $3.28 Billion in 2018 and expected to reach $4.19 Billion by 2022, growing at a CARG of 6.2 percent

Reduction in availability of targeted researchers and physician is expected, due to outbreak of COVID, which is impacting the antibody vaccine
development and analytical testing services
Due to the COVID breakdown, demand for developing antibody vaccine for novel coronavirus is increasing and hence, pharmaceutical
companies are collaborating with research institutions to enhance the speed of antibody vaccine development

Porter's Analysis on Antibody Vaccines

Supplier Power

  • Supplier power is medium as most of the buyers enter into strategic relationships with the preferred suppliers
  • Most of the buyers have particular set of suppliers to be considered for the development process. This is based upon the various technologies and
    processes available.

Barriers to New Entrants

  • Set up and scale up of mammalian cell cultures require time.
  • Buyers prefer to go for strategic relationships in this category. Suppliers currently existing in the market have working relationships with various buyers and the entry of a new entrant would be difficult.

Intensity of Rivalry

  • The rivalry faced by the CMOs is not from the direct competitors, but rather an influx of capacity from the players who were product manufacturers earlier.
  • The differences in the established volume, processes, technologies differentiates the various suppliers in the supply space.
  • The CMO space is growing at a rate greater than the increase in demand.

Threat of Substitutes

  • Monoclonal antibodies operate by mimicking the natural defense mechanism of the human body, and is really effective the areas of Cancer and auto immune diseases.
  • Unless a new technology/process can find an alternative for the treatment, the threat of substitute is really low.

Buyer Power

  • The utilization rates of the supplier facilities are expected to drop going foreword as the suppliers and buyers are expanding at a rate higher than the
    increase in supply.

  •  Most of the buyers outsource high volumes to a supplier often leading to the allotment of a dedicated space.

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

Complimentary 12-month access to Beroe LiVE

Any more questions?

Get in touch with us quickly and easily.

x

COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)